tiprankstipranks
Trending News
More News >
Danaher Corp. (DHR)
NYSE:DHR
US Market
Advertisement

Danaher (DHR) Earnings Dates, Call Summary & Reports

Compare
2,954 Followers

Earnings Data

Report Date
Oct 28, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
1.73
Last Year’s EPS
1.71
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 22, 2025|
% Change Since: -0.97%|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong performance in the bioprocessing and diagnostics segments, alongside challenges in life sciences and high-growth markets. The company's innovation and new product launches highlight a focus on long-term growth, while global trade tensions and market declines in China pose ongoing challenges.
Company Guidance -
Q3 2025
During Danaher Corporation's second quarter 2025 earnings call, the company provided several key metrics and guidance for the year. Danaher reported sales of $5.9 billion for the second quarter, with a core revenue growth of 1.5%. The gross profit margin stood at 59.3%, while the adjusted operating profit margin was 27.3%, flat year-over-year. Adjusted diluted net earnings per share increased by approximately 5% to $1.80. The company also generated $1.1 billion in free cash flow for the quarter, resulting in a year-to-date free cash flow to net income conversion ratio of 143%. Looking ahead, Danaher maintained its full-year core revenue growth guidance at approximately 3% and increased its full-year adjusted diluted net EPS guidance to a range of $7.70 to $7.80. For the third quarter, Danaher anticipates core revenue growth in the low single-digit percent range and an adjusted operating profit margin of approximately 25.5%. The company noted robust growth in its bioprocessing business, with a high single-digit growth outlook for the second half of 2025, and highlighted strong secular growth drivers and a resilient portfolio as key factors supporting these expectations.
Strong Bioprocessing Performance
Bioprocessing business showed strong growth with low double-digit growth in consumables and high single-digit growth in the biotechnology segment.
Free Cash Flow and Earnings Growth
Generated $1.1 billion of free cash flow in the quarter, with adjusted diluted net earnings per share up approximately 5% year-over-year.
New Product Launches and Innovations
Significant investments in new products like Syteva's protein A resins and XenoTOS 8600 mass spectrometry, enhancing long-term competitive positioning.
Resilience in Diagnostics
Diagnostics segment showed core revenue increase of 2%, with Cepheid's non-respiratory revenue growing double digits.
CFO Succession Plan
Announced CFO succession with Matt Gugino taking over, ensuring continuity and leadership strength.

Danaher (DHR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DHR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 28, 2025
2025 (Q3)
1.73 / -
1.71
Jul 22, 2025
2025 (Q2)
1.64 / 1.80
1.724.65% (+0.08)
Apr 22, 2025
2025 (Q1)
1.63 / 1.88
1.92-2.08% (-0.04)
Jan 29, 2025
2024 (Q4)
2.16 / 2.14
2.092.39% (+0.05)
Oct 22, 2024
2024 (Q3)
1.57 / 1.71
2.02-15.35% (-0.31)
Jul 23, 2024
2024 (Q2)
1.57 / 1.72
1.817-5.34% (-0.10)
Apr 23, 2024
2024 (Q1)
1.72 / 1.92
2.092-8.22% (-0.17)
Jan 30, 2024
2023 (Q4)
1.91 / 2.09
2.544-17.85% (-0.45)
Oct 24, 2023
2023 (Q3)
1.81 / 2.02
2.269-10.97% (-0.25)
Jul 25, 2023
2023 (Q2)
1.78 / 1.82
2.446-25.72% (-0.63)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DHR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 22, 2025
$188.07$189.91+0.98%
Apr 22, 2025
$184.67$191.76+3.84%
Jan 29, 2025
$247.07$223.03-9.73%
Oct 22, 2024
$270.93$260.16-3.98%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Danaher Corp. (DHR) report earnings?
Danaher Corp. (DHR) is schdueled to report earning on Oct 28, 2025, Before Open (Confirmed).
    What is Danaher Corp. (DHR) earnings time?
    Danaher Corp. (DHR) earnings time is at Oct 28, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DHR EPS forecast?
          DHR EPS forecast for the fiscal quarter 2025 (Q3) is 1.73.

            Danaher (DHR) Earnings News

            Danaher (NYSE:DHR) Drops on Dismal Q4 Numbers
            Premium
            Market News
            Danaher (NYSE:DHR) Drops on Dismal Q4 Numbers
            1y ago
            Danaher Posts Upbeat Q2 Results; Street Says Buy
            Premium
            Market News
            Danaher Posts Upbeat Q2 Results; Street Says Buy
            3y ago
            Danaher Stock: Attractively Priced Following the Recent Correction
            Premium
            Stock Analysis & Ideas
            Danaher Stock: Attractively Priced Following the Recent Correction
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis